Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)
In: DPaola A, Lcoln T, Skst DJ, Desabra M, Alte FL, Sprger SA. Desn and methods of a double bld randomed placebo-controlled trl of extended-release naltrexone for H-fected, op dependent proners and ja detaees who are transng to the communy. Contemp Cl Trls. 2014 Nov;39(2):256-68. do 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18. Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12. Erratum In: J Subst Abuse Treat. 2017 Jun;77:44. Springer SA, Brown SE, Di Paola A, Altice FL. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015 Dec 1;157:158-65. doi: 10.1016/j.drugalcdep.2015.10.023. Epub 2015 Oct 28. Erratum In: Drug Alcohol Depend. ;161:372. Altice, Frederick L [added]. Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Online
report
Titel: |
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)
|
---|---|
Autor/in / Beteiligte Person: | Baystate Medical Center ; National Institute on Drug Abuse (NIDA) |
Link: | |
Quelle: | DPaola A, Lcoln T, Skst DJ, Desabra M, Alte FL, Sprger SA. Desn and methods of a double bld randomed placebo-controlled trl of extended-release naltrexone for H-fected, op dependent proners and ja detaees who are transng to the communy. Contemp Cl Trls. 2014 Nov;39(2):256-68. do 10.1016/j.cct.2014.09.002. Epub 2014 Sep 18. Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat. 2014 Jul;47(1):35-40. doi: 10.1016/j.jsat.2014.02.008. Epub 2014 Mar 12. Erratum In: J Subst Abuse Treat. 2017 Jun;77:44. Springer SA, Brown SE, Di Paola A, Altice FL. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015 Dec 1;157:158-65. doi: 10.1016/j.drugalcdep.2015.10.023. Epub 2015 Oct 28. Erratum In: Drug Alcohol Depend. ;161:372. Altice, Frederick L [added]. Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations |
Medientyp: | report |
Sonstiges: |
|